The nanoparticle formulation market is projected to grow at a 10% CAGR till 2035, claims Roots Analys

Published: August 2023

In order to improve bioavailability of poorly water-soluble drugs and achieve their targeted delivery, drug developers have inclined towards utilization of nanoparticle formulation technologies and outsourcing certain operations to service providers

Roots Analysis has announced the addition of Nanoparticle Formulation Technologies and Services Market, 2023-2035” report to its list of offerings. 

The advancements in nanotechnology have paved the way for adoption of nanoparticles as a novel mode of drug delivery for therapeutics and vaccines. Moreover, nanoparticles have emerged as a versatile tool for biomedical imaging. However, the formulation of these complex structures is associated with various challenges, such as requirement of extensive technical expertise, high capital investment and stringent regulatory policies to develop nano-based drugs. As a result, outsourcing has become a preferred business model in this domain, allowing drug developers and researchers to leverage a broader range of advanced nanoparticle formulation technologies and cost-effective solutions.

To order this 250+ page report, which features 110+ figures and 115+ tables, please visit this link

Key Market Insights 

Over 100 nanoparticle formulation technologies are available, globally 

Around 80% of the technologies are based on organic nanoparticles, followed by those based on inorganic nanoparticles (24%). Further, more than 50% of the organic nanoparticle formulation technologies have the capability to formulate polymeric nanoparticles.

More than 80 companies claim to offer nanoparticle formulation services

Presently, the market is dominated by the presence of small (2-50 employees) and mid-sized (51-500 employees) players, who represent 85% of the contemporary market landscape. Of these, around 50% of the players are headquartered in North America.

Partnership activity in this domain has increased at a CAGR of 15%, between 2018 and 2022

Around 50% of the agreement were inked in this domain post-2020.Majority of the agreements were technology licensing agreements (17%), followed by research and development agreements (16%) and product development agreements (14%)

Over 1,700 patents have been filed / published related to nanoparticle formulation and development, since 2018

Around 45% of these were granted patents, while over 55% were patent applications. Further, majority of the patent assignees were non-industry players. However, it is worth mentioning that the contribution of industry players in the overall patent filing activity has increased considerably (CAGR of 26%), during the period 2018-2022.

North America and Europe are anticipated to capture more than 80% of the services market share, by 2035

The market in Asia-Pacific is likely to grow at a relatively faster pace (11.7%), in the long-term. Based on type of nanoparticle, majority of the revenue share (63%) is likely to be associated with organic nanoparticles.

To request a sample copy / brochure of this report, please visit this link

Key Questions Answered

  • What are the different types of nanoparticles?
  • How are nanoparticles used in drug delivery?
  • What is the global market size of nanoparticle formulation market (services)?
  • What are the key factors driving the nanoparticle formulation market?
  • What is the current landscape of patents filed in the field of nanoparticle formulation?
  • How many technologies have been developed for the formulation of organic nanoparticles?
  • Which are the leading service providers in the lipid nanoparticle formulation market?
  • What are the leading market segments in the global nanoparticle formulation market (services)?
  • Which region captures the largest share in the nanoparticle formulation market (services)?
  • What is the likely growth rate (CAGR) for nanoparticle formulation market (services)

The financial opportunity within the nanoparticle formulation services market has been analyzed across the following segments:

  • Type of Nanoparticle
    • Organic Nanoparticles
    • Inorganic Nanoparticles
    • Carbon-based Nanoparticles
  • Type of Organic Nanoparticle
    • Polymeric Nanoparticles
    • Lipid Nanoparticles
    • Viral Nanoparticles
    • Protein-based Nanoparticles
    • Other Organic Nanoparticles
  • Type of Inorganic Nanoparticle
    • Metal Nanoparticles
    • Quantum Dots
    • Silica Nanoparticles
    • Magnetic Nanoparticles
    • Other Inorganic Nanoparticles
  • Scale of Operation
    • Preclinical
    • Clinical
    • Commercial
  • Key Geographical Regions 
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and North Africa
    • Latin America

The research includes brief profiles of key players (listed below) engaged in offering technologies and services for nanoparticle formulation; each profile features a brief overview of the company, recent developments and an informed future outlook.

  • Ascension Sciences
  • DIANT Pharma
  • ExonanoRNA
  • Nanoform
  • NanoVation Therapeutics
  • NanoVelos
  • NTT Biopharma
  • Organoid-X BioTech
  • Vaxinano

For additional details, please visit or email  

You may also be interested in the following titles 

  1. Pharmaceutical Polymers / Medical Polymers Market, Industry Trends and Global Forecasts, 2023-2035
  2. Long-Acting Drug Delivery Technologies and Services Market, Industry Trends and Global Forecasts, 2023-2035
  3. Liposome Development and Manufacturing Services Market, Industry Trends and Global Forecasts, 2022-2035

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091


  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry